C
CRL
Charles Riv Labs Intl Inc
173.89
-1.01-0.58%After Hours: 173.89 0.00 0.00%19:35 04/02 EDT
OPEN/PREV CLOSE178.14/169.54
TODAY RANGE173.94-180.79
VOL978.96K
MARKET CAP8.64B
52 WEEK RANGE91.86-228.88
AVG VOL (3M)1.00M
% TURNOVER1.98%
TURNOVER--
P/E (TTM)-60.1161
% RANGE4.04%
EPS(TTM)-2.9122
P/E(FORWARD)24.57
P/B2.723
BVPS64.30
DIVIDEND--
P/S2.146
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.56B
SHARES OUTSTANDING49.34M
NEXT EARNINGS05/05-05/11
FREE FLOAT48.90M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·2d ago
S&P 500 Movers: BKNG, STX
Dow Jones·03/31 20:34
Charles River Laboratories International Inc. Stock Advances 8.0%, Outperforms Peers
MarketWatch·03/31 20:30
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Seeking Alpha·03/29 13:05
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
MarketWatch·03/25 20:30
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Simply Wall St·03/23 17:10
Could Charles River (CRL) Using Locus Cell Tie-Up to Reframe Its Asia-Pacific Growth Strategy?
Seeking Alpha·03/18 16:38
FDA issues guidance on alternatives to animal testing
NASDAQ·03/16 20:56
Charles River Laboratories International is Now Oversold (CRL)
Seeking Alpha·03/15 13:05
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus
Simply Wall St·03/14 21:25
A Look At Charles River Laboratories (CRL) Valuation After Its Earnings Beat And New US$1b Buyback
Simply Wall St·03/13 13:20
Are Charles River’s New Advanced Therapy Deals Quietly Rewriting Its Drug-Development Moat Story (CRL)?
Same Industry
Name/Symbol
Change%
Price